STING Promotes the Progression of ADPKD by Regulating Mitochondrial Function, Inflammation, Fibrosis, and Apoptosis
Biomolecules · 26.09.2024 · 14 (10) · 1215
DOI: 10.3390/biom14101215 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 26.09.2024. Verfasst von Jiao Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA. Hauptthemen laut MEDLINE: Polycystic Kidney, Autosomal Dominant, Mitochondria, Membrane Proteins, Apoptosis. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Li Xiaogang, NIDDK NIH HHS, Zhou Xia.
Abstract (Originalsprache)
Autosomal dominant polycystic kidney disease (ADPKD) is a predominant genetic disease, which is caused by mutations in PKD genes and is associated with DNA damage in cystic cells. The intrinsic stimulator of interferon genes (STING) pathway is crucial for recognizing damaged DNA in the cytosol, triggering the expression of inflammatory cytokines to activate defense mechanisms. However, the precise roles and mechanisms of STING in ADPKD remain elusive. In this study, we show that Pkd1 mutant mouse kidneys show upregulation of STING, which is stimulated by the DNAs of nuclear and mitochondrial origin. The activation of STING promotes cyst growth through increasing (1) the activation of NF-κB in Pkd1 mutant cells and (2) the recruitment of macrophages in the interstitial and peri-cystic regions in Pkd1 mutant mouse kidneys via NF-κB mediating the upregulation of TNF-α and MCP-1. Targeting STING with its specific inhibitor C-176 delays cyst growth in an early-stage aggressive Pkd1 conditional knockout mouse model and a milder long-lasting Pkd1 mutant mouse model. Targeting STING normalizes mitochondrial structure and function, decreases the formation of micronuclei, induces Pkd1 mutant renal epithelial cell death via p53 signaling, and decreases renal fibrosis in Pkd1 mutant mouse kidneys. These results support that STING is a novel therapeutic target for ADPKD treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.
- Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA.
ORCID-Profile: Jiao Wu, Shasha Cheng
Förderung
- Li Xiaogang
- NIDDK NIH HHS
- Zhou Xia
- NIH
- DOD
- PKD Foundation Research Grant
Zitieren
APA
Wu, J., Cheng, S., Lee, G., Agborbesong, E., Li, X., Zhou, X., & Li, X. (2024). STING Promotes the Progression of ADPKD by Regulating Mitochondrial Function, Inflammation, Fibrosis, and Apoptosis. Biomolecules, 14(10), 1215. https://doi.org/10.3390/biom14101215
Vancouver
Wu J, Cheng S, Lee G, Agborbesong E, Li X, Zhou X, et al. STING Promotes the Progression of ADPKD by Regulating Mitochondrial Function, Inflammation, Fibrosis, and Apoptosis. Biomolecules. 2024;14(10):1215. doi:10.3390/biom14101215
BibTeX
@article{Wu2024,
author = {Wu, Jiao and Cheng, Shasha and Lee, Geoffray and Agborbesong, Ewud and Li, Xiaoyan and Zhou, Xia and Li, Xiaogang},
title = {STING Promotes the Progression of ADPKD by Regulating Mitochondrial Function, Inflammation, Fibrosis, and Apoptosis},
journal = {Biomolecules},
year = {2024},
volume = {14},
number = {10},
pages = {1215},
doi = {10.3390/biom14101215}
}
EUVIMED